Search all trials

Find therapies in clinical trials near you – page 4

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Thalassaemia beta+2

Recruiting

InvestigationalNo placebo

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

InvestigationalNo placebo

Poland

Participants:18–64 years
Substances:(S)-4,5-Dihydro-2-[2-Hydroxy-4-(3,6-Dioxaheptyloxy)Phenyl]-4-Methyl-4-Thiazolecarboxylic Acid

Contact Research Centre

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Recruiting

Registered drugNo placebo

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Haematological malignancy

Recruiting

Registered drugNo placebo

Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Tafasitamab

Contact Research Centre

B-cell lymphoma recurrent+1

Recruiting

Registered drugNo placebo

Study of MEN1703 and Glofitamab for Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Glofitamab

Contact Research Centre

Aortic valve stenosis

Not yet recruiting

Investigational

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Embolism

Not yet recruiting

Investigational

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Regn7508

Contact Research Centre

Myasthenia gravis

Not yet recruiting

Investigational

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Dnth103

Contact Research Centre

Chronic lymphocytic leukaemia+2

Not yet recruiting

Registered drugNo placebo

Clinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin

Contact Research Centre

Embolism venous

Not yet recruiting

Investigational

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Rbd4059

Contact Research Centre

Plasma cell myeloma

Not yet recruiting

Registered drugNo placebo

Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Daratumumab

Contact Research Centre

Hormone-refractory prostate cancer

Not yet recruiting

Registered drugNo placebo

Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Heart failure with reduced ejection fraction

Not yet recruiting

Investigational

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Crd-4730

Contact Research Centre

Find therapies in clinical trials near you – page 4

97 trials match your criteria

Thalassaemia beta+2

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Study Comparing Odronextamab with Rituximab and Chemotherapy for Patients with Untreated Follicular Lymphoma

Haematological malignancy

Continued Treatment Study for Patients with Blood Cancers Using Tafasitamab

B-cell lymphoma recurrent+1

Study of MEN1703 and Glofitamab for Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Aortic valve stenosis

A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

Embolism

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Myasthenia gravis

Efficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study

Chronic lymphocytic leukaemia+2

Clinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma

Embolism venous

Safety, Tolerability and Effect of RBD4059 Injection in Adults with Prior VTE After Anticoagulant Therapy and Cancer Patients at High Risk of VTE

Plasma cell myeloma

Phase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients

Hormone-refractory prostate cancer

Phase III Randomized Open‑Label Trial of BNT324 vs Docetaxel Plus Prednisone in Patients with Metastatic Castration‑Resistant Prostate Cancer

Heart failure with reduced ejection fraction

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.